| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Colorectal Cancer in Patients with Inflammatory Bowel Disease
|
Vagefi, Parsia A.
|
|
2005
|
4 |
5 |
p. 313-319
7 p.
|
article
|
| 2 |
Evolution of FOLFOX Regimens in the Treatment of Advanced Colorectal Cancer
|
Reddy, G. Kesava
|
|
2005
|
4 |
5 |
p. 296-299
4 p.
|
article
|
| 3 |
5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study
|
D'Andre, Stacy
|
|
2005
|
4 |
5 |
p. 325-331
7 p.
|
article
|
| 4 |
Importance of Preclinical Investigations of the Integration of Capecitabine into Polychemotherapy Regimens
|
Danesi, Romano
|
|
2005
|
4 |
5 |
p. 344-
1 p.
|
article
|
| 5 |
Long-Term Results of Local Excision with and Without Chemoradiation for Adenocarcinoma of the Rectum
|
Wentworth, Stacy
|
|
2005
|
4 |
5 |
p. 332-335
4 p.
|
article
|
| 6 |
Lymphatic Mapping and Sentinel Node Analysis in Colon Cancer
|
Martinez, Steve R.
|
|
2005
|
4 |
5 |
p. 320-324
5 p.
|
article
|
| 7 |
Staging of Colorectal Cancer: Past, Present, and Future
|
Horton, Janet K.
|
|
2005
|
4 |
5 |
p. 302-312
11 p.
|
article
|
| 8 |
Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan
|
Cao, Shousong
|
|
2005
|
4 |
5 |
p. 336-343
8 p.
|
article
|
| 9 |
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial
|
Reddy, G. Kesava
|
|
2005
|
4 |
5 |
p. 300-301
2 p.
|
article
|
| 10 |
The Development of the FOLFOX Regimens as a Treatment Standard of Advanced Colorectal Cancer
|
Chu, Edward
|
|
2005
|
4 |
5 |
p. 292-
1 p.
|
article
|
Journal description